-
Moderna Ends “Venture” Experiment, Dissolves Four Startups
Xconomy | Moderna Therapeutics announced today that it is ending the experiment to hatch startups as wholly-owned subsidaries, bringing all their experimental drugs back into the Moderna nest.
Sep 14, 2017
-
Brainin Joins WuXi NextCODE, Prioritizes Actionability Of Genome
Bio-IT World | WuXi NextCODE today announced the appointment of Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.
Sep 13, 2017
-
IBM Expands Certified Public Cloud Infrastructure For SAP HANA
Bio-IT World Brief | IBM today announced the availability of new SAP-certified bare metal servers for SAP HANA platform deployments in the IBM Cloud and new configurations for VMware environments. The new cloud infrastructure-as-a-service solutions are designed to give enterprises the power and performance they need to manage their mission-critical applications running on SAP HANA.
Sep 12, 2017
-
Alexion Cutting 600 Jobs And Moving Headquarters In Major Shakeup
STAT | Alexion, once one of biotech's biggest success stories, is eliminating 20% of its global workforce as it struggles to map out a brighter future.
Sep 12, 2017
-
Long-Read Sequencing Data Enables Structural Variant Discovery For Clinical And Disease Research
Bio-IT World Contributed Commentary | The advent of single molecule, real-time sequencing, with average read lengths exceeding 12 kb, has allowed scientists to reliably detect structural variation for the first time. These latest studies have shown that previous human genome data sets have dramatically underrepresented the number of structural variants—along with their effect on health and disease.
Sep 11, 2017
-
Amid Setback Researchers Forge Ahead with “Off-the-Shelf” Immune Cells to Treat Cancer
MIT Technology Review | The approach could treat patients in dire need faster at a lower price, but major questions remain about safety.
Sep 8, 2017
-
Patients Without Traditional Cancer Screening Find Allies In Maccabi And Medial EarlySign
Bio-IT World | 2017 Best Practices Awards | Maccabi Healthcare System is using Medial EarlySign’s clinical decision support tool to find colon cancer patients among individuals who didn’t go through traditional channels for screening.
Sep 8, 2017
-
Does Your Genome Predict Your Face? Not Quite Yet
MIT Technology Review | Genomics pioneer J. Craig Venter says if he had your genome he could pick you out of a crowd. According to two experts who reviewed the famed genomics expert's claim, however, that's not necessarily true.
Sep 7, 2017
